Morpholino

MO1-gbp4

ID

ZDB-MRPHLNO-170915-6

Name

MO1-gbp4

Previous Names

None

Target

gbp4 (1)

Sequence

5' - GCTGTTTGTGTGTCTCTAACCTGTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-gbp4

Expressed Gene	Anatomy	Figures
gata1a	whole organism	Fig. 4 from Tyrkalska et al., 2019
spi1b	whole organism	Fig. 4 from Tyrkalska et al., 2019

Phenotype

Phenotype resulting from MO1-gbp4

Phenotype	Fish	Figures
cysteine-type endopeptidase activity decreased occurrence, abnormal	i114Tg + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2019 Fig. 2, Fig. 3 from Tyrkalska et al., 2016
neutrophil decreased amount, abnormal	i114Tg + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2019 Fig. S8 from Tyrkalska et al., 2016
whole organism Ab2-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2016
whole organism Ab4-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2016
whole organism Ab3-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2016
whole organism Ab1-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	Fig. 1 from Tyrkalska et al., 2016

Phenotype of all Fish created by or utilizing MO1-gbp4

Phenotype	Fish	Conditions	Figures
whole organism decreased life span, exacerbated	WT + MO1-gbp4	chemical treatment by environment: prostaglandin J2, bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 9 from Tyrkalska et al., 2016
cysteine-type endopeptidase activity decreased occurrence, abnormal	WT + MO1-gbp4	control	Fig. 2, Fig. 3 from Tyrkalska et al., 2016
cysteine-type endopeptidase activity decreased occurrence, abnormal	WT + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 1, Fig. 3 from Tyrkalska et al., 2016
whole organism decreased life span, ameliorated	WT + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium, chemical treatment by environment: prostaglandin E2	Fig. 9 from Tyrkalska et al., 2016
whole organism decreased life span, exacerbated	WT + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 7, Fig. 9, Fig. S8 from Tyrkalska et al., 2016
cysteine-type endopeptidase activity occurrence, ameliorated	WT + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 2, Fig. 4, Fig. 5 from Tyrkalska et al., 2016
whole organism Ab4-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	standard conditions	Fig. 1 from Tyrkalska et al., 2016
whole organism Ab3-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	standard conditions	Fig. 1 from Tyrkalska et al., 2016
whole organism decreased life span, exacerbated	WT + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium, chemical treatment by environment: 15-deoxy-Delta(12,14)-prostaglandin J2	Fig. 9 from Tyrkalska et al., 2016
whole organism Ab2-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	standard conditions	Fig. 1 from Tyrkalska et al., 2016
whole organism Ab1-gbp4 labeling decreased amount, abnormal	WT + MO1-gbp4	standard conditions	Fig. 1 from Tyrkalska et al., 2016
whole organism decreased life span, ameliorated	WT + MO1-gbp4	chemical treatment by environment: prostaglandin D2, bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 9 from Tyrkalska et al., 2016
cysteine-type endopeptidase activity decreased occurrence, abnormal	i114Tg + MO1-gbp4	control	Fig. 1 from Tyrkalska et al., 2019
neutrophil decreased amount, abnormal	i114Tg + MO1-gbp4	control	Fig. 1 from Tyrkalska et al., 2019 Fig. S8 from Tyrkalska et al., 2016
whole organism decreased life span, ameliorated	sh267Tg; ums2Tg + MO1-gbp4	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2016
whole organism gata1a expression increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO1-gbp4	control	Fig. 4 from Tyrkalska et al., 2019
whole organism spi1b expression decreased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO1-gbp4	control	Fig. 4 from Tyrkalska et al., 2019
whole organism Ab2-gata1a labeling increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO1-gbp4	control	Fig. 4 from Tyrkalska et al., 2019

Citations